MedTrace Logo

Assessment of Two New Electronic Cigarettes in Cigarette Smokers

NCT03435562 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2020-08-03

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine differences in nicotine delivery, user behavior, subjective effects, and physiological effects, when cigarette smokers use an two new electronic cigarette devices (JUUL and IQOS) relative to their using their own brand of cigarettes.

Conditions

  • Electronic Cigarettes

Interventions

OTHER

JUUL electronic cigarette

Effects of JUUL electronic cigarette use.

OTHER

IQOS electronic cigarette

Effects of IQOS electronic cigarette use.

OTHER

Own Brand cigarette

Effects of own brand cigarette use.

Sponsors & Collaborators

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Alison Breland, PhD · Virginia Commonwealth University

Study Design

Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-03
Primary Completion
2019-08-16
Completion
2019-08-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03435562 on ClinicalTrials.gov